Hollitt, Georgina L
Qassim, Ayub
Thomson, Daniel
Schmidt, Joshua M
Nguyen, Thi Thi
Landers, John
MacGregor, Stuart
Siggs, Owen M
Souzeau, Emmanuelle
Craig, Jamie E
Funding for this research was provided by:
National Health and Medical Research Council
Glaucoma Australia
Article History
Received: 19 April 2023
Accepted: 14 September 2023
First Online: 24 October 2023
Declarations
:
: OM Siggs, S MacGregor and JE Craig report holding equity in Seonix Bio. S MacGregor, and JE Craig are listed as co-inventors on a patent application for the use of genetic risk scores to determine risk and guide treatment for glaucoma. Georgina L Hollitt, Ayub Qassim, Daniel Thomson, Joshua M Schmidt, Thi Thi Nguyen, John Landers, Emmanuelle Souzeau – None.
: This prospective cohort study was approved by the Southern Adelaide Clinical Human Research Ethics Committee (SAC HREC) and adheres to the Revised Declaration of Helsinki. HREC reference number: HREC/20/SAC/188. Informed consent was obtained from all individual participants included in the study.
: Not applicable.